Key result
Prior MitraClip implantation did not affect 2-year survival compared to no prior MitraClip in patients undergoing left ventricular assist device implantation.
Why the study?
The interactions and hemodynamic impact of prior transcatheter percutaneous mitral valve repair had not been investigated in patients undergoing LVAD implantation, with concerns for hemodynamic adverse effects from altered mitral valve flow.
Does prior transcatheter percutaneous mitral valve repair impact mortality or cardiovascular complications in patients undergoing left ventricular assist device implantation?
Observational (n=119)
No
Does prior transcatheter percutaneous mitral valve repair impact mortality or cardiovascular complications in patients undergoing left ventricular assist device implantation?
Answers are grounded in this paper and cite their sources.
Prior transcatheter mitral valve repair does not adversely impact mortality or cardiovascular complications in patients subsequently undergoing LVAD implantation.
The interactions and hemodynamic impact of transcatheter percutaneous mitral valve repair (TMR) have not yet been investigated in patients undergoing left ventricular assist device (LVAD) implantation, but hemodynamic adverse effects are feared in the combination of TMR and LVAD for altered mitral valve flow. This study investigated the hemodynamic interplay in combination of TMR and LVAD in 119 patients, and propensity score match analysis revealed no difference in both perioperative mortality and 2-year follow-up survival (p = 0.84). Nonetheless, postoperatively mean pulmonary arterial pressure, pulmonary capillary wedge pressure, and cardiac index improved, and multivariable cox regression analysis at 2 years identified preoperative total bilirubin and temporary right ventricular mechanical circulatory support as independent risk factors for all-cause mortality but not TMR. Prior TMR has no impact on mortality or cardiovascular complications in patients with LVAD.
No takes yet. Share an insight, caveat, or question.
Fox et al. (2021) conducted an observational in End-stage heart failure with severe functional mitral regurgitation (n=119). Prior MitraClip (transcatheter mitral valve repair) vs. No prior MitraClip was evaluated on 2-year survival (HR 1.06, 95% CI 0.28-4.10, p=0.93). Prior MitraClip implantation did not affect 2-year survival compared to no prior MitraClip in patients undergoing left ventricular assist device implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: